The results for kidney cancer and lung cancer were partially different from those obtained in PrognoScan: ACE2 had a positive impact on OS (HR = 0.44, log-rank P = 0.0063) but not on RFS (HR = 1.79, log-rank P = 0.13) in KIRP (Figures 3C,D); ACE2 was protective in LUAD (OS: HR = 0.6, log-rank P = 0.0011; RFS: HR = 0.62, log-rank P = 0.023) (Figures 3G,H) but detrimental in LUSC (OS: HR = 1.62, log-rank P = 0.00099; RFS: HR = 1.62, log-rank P = 0.065) (Figures 3I,J). This evidence concerns the gene ACE2 and lung carcinoma.